Results 111 to 120 of about 79,138 (287)

Bronchodilator responsiveness in patients with COPD

open access: yesEuropean Respiratory Journal, 2008
The degree of acute improvement in spirometric indices after bronchodilator inhalation varies among chronic obstructive pulmonary disease (COPD) patients, and depends upon the type and dose of bronchodilator and the timing of administration.
D. Tashkin   +6 more
semanticscholar   +1 more source

Inhaled corticosteroids versus long-acting beta -agonists for chronic obstructive pulmonary disease (Review). [PDF]

open access: yes, 2011
Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler.
Agarwal   +105 more
core   +2 more sources

Evaluation of gut modulatory and bronchodilator activities of Amaranthus spinosus Linn.

open access: yesBMC Complementary and Alternative Medicine, 2012
BackgroundThe aqueous-methanolic extract of Amaranthus spinosus (A. spinosus Linn.,) whole plant, was studied for its laxative, spasmolytic and bronchodilator activities to validate some of its medicinal uses.MethodsThe crude extract of A.
M. A. Chaudhary   +5 more
semanticscholar   +1 more source

Can spirometric norms be set using pre- or post- bronchodilator test results in older people?

open access: yesRespiratory Research, 2012
Background Chronic Obstructive Pulmonary Disease (COPD) is defined by post-bronchodilator spirometry. Data on “normal values” come predominantly from pre-bronchodilator spirometry. The effects of this on diagnosis are unknown.
Kato Bernet   +6 more
doaj   +1 more source

Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease [PDF]

open access: yes, 2012
BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease.
Aaron   +47 more
core   +1 more source

BRONCHODILATOR [PDF]

open access: bronze, 1958
JOHN W. PENDER
openalex   +1 more source

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial

open access: yesInternational Journal of COPD, 2019
Kentaro Machida,1,* Tomotaka Kawayama,2,* Masaharu Kinoshita,3,* Masakazu Ichinose,4 Tohru Tsuda,5 Shohei Takata,6 Hiroshi Koto,7 Makoto Yoshida,8 Yoshinori Ashihara,9 Masaru Kawashima,10 Hideaki Suna,10 Hiromasa Inoue1 1Department of Pulmonary Medicine,
Machida K   +11 more
doaj  

Comparative study of the bronchodilator efficacy and adverse effects of salbutamol and hyoscine butylbromide in horses with severe asthma

open access: yesJournal of Veterinary Internal Medicine
Background Salbutamol and hyoscine butylbromide (HBB) are commonly used bronchodilators in horses with severe asthma (SA). Objective To compare the bronchodilation potency, duration, and adverse effects of salbutamol and HBB in SA.
Berta Mozo Vives   +2 more
doaj   +1 more source

Aerosols, Bronchodilators and Mucolytic Agents [PDF]

open access: bronze, 1962
Frank W. Lovejoy, Paul E. Morrow
openalex   +1 more source

The role of bronchodilator treatment in the prevention of exacerbations of COPD

open access: yesEuropean Respiratory Journal, 2012
Exacerbations of chronic obstructive pulmonary disease (COPD) are natural events in the progression of the disease, and are characterised by acute worsening of symptoms, especially dyspnoea. These heterogeneous events follow increased airway inflammation,
J. Wedzicha, M. Decramer, T. Seemungal
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy